Bordeaux, France-based Implanet reported the first surgical procedures utilizing Jazz Lock have been a success.
Here are five insights:
1. Hospitals in the United States, France and Italy have used the Jazz Lock, with more than 25 cases illustrating initially positive results.
2. Implanet has plans for a wide-scale international launch of Jazz Lock by the end of 2016.
3. Jazz Lock has CE marking and 501k clearance.
4. Jazz Lock is intended for spine disorder surgery, and the implant gives surgeons an optimized and reproducible surgical technique.
5. Jazz Lock connects the rod with an innovating locking system, thereby eliminating the need for a locking screw.
"As announced following the regulatory clearance, Jazz Lock is the first component of an innovative range of band products designed for degenerative spine disorders that will rapidly be launched in accordance with our business plan," said Ludovic Lastennet, CEO of Implanet. "The positive results obtained in the first surgical procedures illustrate this implant's potential for patients and surgeons alike. Jazz Lock further expands the breadth of our product offering, with its launch scheduled for upcoming major spine congresses: Eurospine in Berlin in early October and NASS in Boston in late October."
More articles on devices:
33% of orthopedic surgeons to use robotic systems by 2018: 6 things to know
GE Healthcare receives FDA clearance for MAGiC MR technique: 5 things to know
Medtronic advances neurostimulation devices market; spinal cord stimulation devices dominate market share — 7 observations